Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modified clostridial toxins with enhanced translocation capabilities and altered targeting activity for clostridial toxin target cells

Modified clostridial toxins with enhanced translocation capabilities and altered targeting activity for clostridial toxin target cells

US Patent 7993656 · Granted Aug 9, 2011

Estimated economic value: $24,227,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Imidazopyrimidines as EED inhibitors and the use thereof2024
Anti-CD39 antibodies and use thereof2024
Fused 1,4-oxazepines as BET protein degraders2022
Immuno-based botulinum toxin serotype A activity assays2022
Immuno-based botulinum toxin serotype A activity assays2022
BET bromodomain protein degraders with cleavable linkers2022
Immuno-based botulinum toxin serotype A activity assays2022
Immuno-based botulinum toxin serotype A activity assays2022
Fusion proteins comprising a non-cytotoxic protease, a translocation domain, and2022
Fusion proteins comprising a non-cytotoxic protease, a translocation domain, and2022
Microneedle array with active ingredient2021
Botulinum neurotoxin for treatment of disorders associated with melanocyte hyper2021